Clark Financial Services Group Inc. BD Acquires New Shares in Cencora, Inc. $COR

Clark Financial Services Group Inc. BD bought a new stake in Cencora, Inc. (NYSE:COR) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,549 shares of the company’s stock, valued at approximately $528,000.

Several other institutional investors have also recently bought and sold shares of COR. United Bank boosted its stake in shares of Cencora by 4.5% in the 2nd quarter. United Bank now owns 7,032 shares of the company’s stock valued at $2,109,000 after purchasing an additional 305 shares in the last quarter. Dorsey & Whitney Trust CO LLC lifted its stake in Cencora by 3.7% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 1,596 shares of the company’s stock valued at $479,000 after purchasing an additional 57 shares during the last quarter. Pinnacle Wealth Planning Services Inc. boosted its position in Cencora by 16.3% in the second quarter. Pinnacle Wealth Planning Services Inc. now owns 1,019 shares of the company’s stock valued at $306,000 after buying an additional 143 shares in the last quarter. Empowered Funds LLC boosted its position in Cencora by 10.6% in the second quarter. Empowered Funds LLC now owns 20,128 shares of the company’s stock valued at $6,035,000 after buying an additional 1,922 shares in the last quarter. Finally, Wealthspire Advisors LLC bought a new stake in shares of Cencora during the second quarter worth $425,000. Institutional investors and hedge funds own 97.52% of the company’s stock.

Cencora Price Performance

Shares of NYSE:COR opened at $332.06 on Friday. The firm has a market cap of $64.59 billion, a PE ratio of 39.91, a price-to-earnings-growth ratio of 1.51 and a beta of 0.68. The firm’s fifty day moving average is $355.08 and its 200-day moving average is $339.36. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. Cencora, Inc. has a 52 week low of $264.33 and a 52 week high of $377.54.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating analysts’ consensus estimates of $4.04 by $0.04. The business had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.Cencora’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $3.73 earnings per share. Sell-side analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were paid a $0.60 dividend. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. Cencora’s dividend payout ratio is presently 28.85%.

Insider Activity

In other news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on COR. Bank of America dropped their price target on Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research note on Monday, January 5th. Barclays boosted their price objective on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Wells Fargo & Company upped their target price on Cencora from $405.00 to $429.00 and gave the stock an “overweight” rating in a report on Tuesday, February 10th. Evercore reiterated an “outperform” rating on shares of Cencora in a research report on Tuesday. Finally, Leerink Partners reissued an “outperform” rating on shares of Cencora in a research note on Tuesday. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Cencora has an average rating of “Moderate Buy” and an average price target of $403.17.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.